|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.66 USD | +1.33% |
|
-3.96% | +23.09% |
| 05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
| 05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
Cellebrite DI Ltd. updated revenue guidance for the year of 2023. For the year, company updates revenue guidance to $315 million - $320 million compared to $310 million - $320 million as previously announced.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.09% | 2.16B | |
| +8.91% | 86.53B | |
| +5.14% | 78.44B | |
| -16.20% | 53.55B | |
| +26.18% | 48.39B | |
| +28.93% | 45.84B | |
| -34.05% | 41.75B | |
| +66.72% | 38.57B | |
| -0.36% | 27.38B | |
| -26.47% | 21.22B |
CELLEBRITE DI LTD. 
